Agency Information Collection Activities; Proposed Collection; Comment Request; Pet Event Tracking Network-State, Federal Cooperation to Prevent Spread of Pet Food Related Diseases, 43990-43992 [2010-18303]
Download as PDF
43990
Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices
associated with drug response, CVM
would potentially have a scientific basis
for modifying recommendations with
regard to SLENTROL use.
To conduct the study, FDA would
seek the voluntary participation of
veterinarians in the private sector. FDA
would contact veterinarians who have
reported adverse events with
SLENTROL to FDA using a Form FDA
1932a, or veterinarians who have posted
adverse experiences with SLENTROL on
Internet Web sites or other public
forums with their contact information,
to ask them if they are willing to
participate in the study. If the
veterinarians are willing to participate,
and the owners of the animals consent,
FDA would provide the veterinarians
with a package that includes
instructions and materials for taking a
blood sample and buccal swab from the
animal, a postage paid envelope to
return the samples, and a brief ‘‘Sample
Collection’’ form to be filled out by the
veterinarian. The ‘‘Sample Collection’’
form collects information that includes
the date and type of sample taken,
information about the treated dog
(breed, age, gender and neuter status,
type of food), and information about
past SLENTROL use and adverse events
experienced. FDA anticipates that
participating veterinarians will take the
samples during routine office visits from
pet owners for their pets, and that pet
owners will not make a special trip to
the veterinarian for the purpose of
participation in the study. FDA’s goal is
to obtain at about 100 samples.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 U.S.C. 512/ Form FDA
3754
Annual Frequency
per Response
100
1 There
Total Annual
Responses
1
Hours per
Response
100
Total Hours
0.5
50
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 U.S.C. 512/ Form No.
No. of
Record-keepers
3754
sroberts on DSKD5P82C1PROD with NOTICES
1 There
Annual Frequency per
per Record-keeping
100
Total Annual
Records
1
Hours per
Record
100
Total Hours
0.5
50
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s estimates that it will take a
veterinarian approximately 30 minutes
to obtain the owner’s consent, take the
blood and buccal samples, and fill out
the ‘‘Sample Collection’’ form. This
includes the time necessary for a
veterinarian to read instructions for
taking samples, to search the animal’s
medical records to obtain information
necessary to complete the form, such as
the adverse events that occurred after
initiating SLENTROL treatment, and to
mail the samples and form to FDA. As
noted previously, FDA anticipates that
participating veterinarians will obtain
the samples during routine office visits
from the pet owner for their pet, and
therefore no reporting burden is
contained in this collection of
information with respect to the owners
of the animals involved in the study.
Regarding recordkeeping, it is the
customary and usual practice of
veterinarians to keep medical records
for their patients, and the agency
believes that the proposed collection of
information would not contain any
additional recordkeeping burdens.
However, FDA has estimated that an
additional 30 minutes of recordkeeping
will be necessary to maintain records
necessary to participate in the study.
VerDate Mar<15>2010
16:30 Jul 26, 2010
Jkt 220001
Dated: July 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–18304 Filed 7–26–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010–N–0368]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Pet Event Tracking
Network—State, Federal Cooperation
to Prevent Spread of Pet Food Related
Diseases
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the paperwork requirements for the
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
proposed Pet Event Tracking Network
(PETNet) cooperative Federal and State
initiative.
DATES: Submit either electronic or
written comments on the collection of
information by September 27, 2010.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793, Denver.presley@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
E:\FR\FM\27JYN1.SGM
27JYN1
Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires Federal agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Pet Event Tracking Network—State,
Federal Cooperation to Prevent Spread
of Pet Food Related Diseases—21 U.S.C.
342 and 343, Section 1002(b) of the FDA
Amendments Act of 2007. Stat. 823
(2007) (OMB Control No. 0910–NEW)
In August, 2008, FDA sponsored the
‘‘Gateway to Food Protection’’ meeting,
also known as the ‘‘50–State’’ meeting.
The meeting included representatives
from other Federal agencies, the States,
localities, territories, and tribal partners,
and was held to address the challenges
necessary to ensure the safety of the
U.S. food supply. Work groups were
formed during the meeting which met
and produced recommendations in
specific topic areas. One of the
workgroups, the Outbreaks/Food-Borne
and Feed-Borne Investigations
Workgroup, created a subgroup
consisting of veterinarians, animal feed
regulators, and others involved with
animal health issues. This subgroup
developed an ambitious proposal for an
early warning system to identify, track
and report disease outbreaks in
companion animals or contamination
incidents concerning pet food or
animals feed, which they named
PETNet. The PETNet proposal was
developed in response to the 2007
VerDate Mar<15>2010
16:30 Jul 26, 2010
Jkt 220001
outbreak that occurred in companion
animals that was associated with the
deliberate adulteration of pet food
components, such as wheat gluten, with
melamine. As envisioned by the
subgroup at that time, PETNet would
include a system for reporting outbreaks
and would be supported by adequate
diagnostic laboratory facilities and an
established mechanism for conducting
national epidemiological investigations.
The PETNet subgroup subsequently
met twice in face-to-face meetings, in
May and November, 2009, during which
time the proposed scope of PETNet was
streamlined to focus the program on
information sharing, rather than
epidemiology or other aspects. One of
the main concerns of FDA’s State
regulatory partners regarding FDA’s
handling of the melamine incident was
that many States provided information
to FDA, but the information reported by
the States to FDA and other information
in the possession of FDA was not shared
by FDA with the States. States believed
that if they had received more
information about what was going on in
a timely manner, they could perhaps
have taken appropriate action to
safeguard animal and the public health
by using their own regulatory
authorities and resources. The agency
agreed with the States, and thus decided
to focus PETNet on being a system for
sharing information between FDA, other
Federal agencies, and the States about
food-borne illness outbreaks in
companion animals. By the end of the
November, 2009, meeting, this revised
vision of PETNet was firmly established
with many of the details about the
system in place.
FDA is planning to implement an
initiative called ‘‘The Pet Event Tracking
Network’’ (PETNet) that will allow FDA
and its State partners to quickly and
effectively exchange information about
outbreaks of illness in companion
animals associated with pet food. FDA
has worked closely with its Federal and
State partners to develop the PETNet,
and believes that it will serve an
important function in protecting the
public and animal health.
PETNet will be a secure, internetbased network comprised of the FDA,
other Federal agencies, and State
regulatory agencies/officials that have
authority over pet food. The Network
will provide timely and relevant
information about pet food-related
incidents to FDA, the States, and other
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
43991
Federal Government agencies charged
with protecting animal and public
health. FDA intends to identify and
invite State participants from all 50
States to participate in PETNet.
Members of the network will be able to
both receive alerts about pet food
incidents, as well as create alerts when
they are aware of a pet food incident
within their jurisdiction. The
information will be used to help State
and Federal regulators determine how
best to use inspectional and other
resources to either prevent or quickly
limit the adverse events caused by
adulterated pet food. Many states have
regulatory authority beyond that of the
FDA and often can be in a position to
act independently of FDA with the
information they will receive from the
Pet Event Tracking Network.
Use of the system, including the
reporting of incidents by States to the
FDA, will be entirely voluntary. The
PETNet system will be housed in Food
Shield, a proprietary software system,
and will be accessible only to members
via password. The system will make use
of a standardized electronic form
housed on FoodShield to collect and
distribute basic information about pet
food-related incidents. The form
contains the following data elements,
almost all of which are drop down
menu choices: The species involved,
clinical signs, number of animals
exposed, number of animals affected,
animal ages, date of onset, name and
type of pet food involved, the
manufacturer and distributor of the pet
food (if known), the State where the
incident occurred, the origin of the
information, whether there are
supporting laboratory results, and
contact information for the reporting
PETNet member (i.e. name, telephone
number). The form would be filled out
and submitted by a PETNet member on
FoodShield, at which time it will be
available to other PETNet members.
Thus, the information will be entered
and received by PETNet members in as
close to real time as possible. FDA has
designed the form itself to contain only
the essential information necessary to
alert PETNet members about pet foodrelated incidents. For further
information, such as laboratory results,
PETNet members can contact the
reporting PETNet member.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\27JYN1.SGM
27JYN1
43992
Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices
TABLE 1.—ESTIMATED REPORTING BURDEN
21 U.S.C. Section 342 & 343/Section 1002(b) 2007 Amendments /
Form FDA
No. of
Respondents
Form FDA 3756
1 There
Annual Frequency
per Response
50
Total Annual
Responses
10
500
Total Hours
20/60
167
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA estimates that each State will
report (i.e., fill out the PETNet form to
alert other PETNet members about a pet
food-related incident) approximately 10
times per year. This estimate represents
the maximum number of reports that
FDA expects a State to submit in a year,
and in many cases the number of reports
submitted by a State will probably be far
less. FDA believes that, given the form
only has 11 items and most are drop
down fields, 20 minutes is a sufficient
amount of time to complete the form.
State regulatory officials responsible for
pet food already possess computer
systems and have the internet access
necessary to participate in PETNet, and
thus there are no capital expenditures
associated with the reporting.
Regarding recordkeeping, State
regulatory officials who report on
PETNet receive the reportable
information from consumers in their
States in the course of their customary
and regular duties. Further, these
individuals already maintain records of
such consumer complaints in the course
of their duties which are sufficient for
the purposes of reporting on PETNet.
Therefore, FDA believes that the
proposed collection of information does
not have additional recordkeeping
requirements.
Dated: July 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–18303 Filed 7–26–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
ADDRESSES:
Therapeutics for the Treatment and
Prevention of Atherosclerosis and
Cardiovascular Disease
Description of Invention: This
technology consists of peptides and
peptide-analogues that enhance
clearance of excess cholesterol in cells
and do not exhibit the cytotoxicity that
has hampered development of similar
potential therapeutics.
Briefly, apolipoprotein A–1 (ApoA–1)
promotes cholesterol efflux from cells
and its concentration is inversely
correlated with atherosclerotic events.
The isolated peptidic component of
ApoA–1 that acts within the cholesterol
secretion pathway is therapeutic
towards atherosclerosis but exhibits
cytotoxic effects. In contrast, our
inventors have derivatized that ApoA–
1 peptide which is both less cytotoxic
and more active than the underivatized
component in initial studies. This
potential therapeutic is similar to high
density lipoprotein (HDL) therapy and
may complement statin-mediated
reduction of pro-atherogenic
lipoproteins.
AGENCY:
Potential Applications
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
Federally-funded research and
• Treatment and prevention of
atherosclerosis.
• Treatment and prevention of
cardiovascular disease, coronary artery
disease, heart attack, stroke and
inflammation.
• Therapeutic or preventative coating
for a heart or vascular implant.
• Alternative to HDL therapy.
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
sroberts on DSKD5P82C1PROD with NOTICES
Hours per
Response
SUMMARY:
VerDate Mar<15>2010
16:30 Jul 26, 2010
Jkt 220001
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Potential Advantages
• Enhanced cytotoxicity profile.
• Enhanced hydrophilicity profile.
• Complements statin-based
therapies.
• Oral delivery approaches in
development.
Development Status: Early stage with
in vitro proof of concept data.
Market: The CDC indicates that heart
attacks account for 26% of deaths in the
United States of which atherosclerosis is
a significant contributing factor or
cause. Global sales for cardiovascular
therapeutics are expected to exceed
$50b in 2010.
Inventors: Amar A. Sethi (NHLBI) et
al.
Patent Status: U.S. Provisional
Application No. 61/265,291 filed 30
Nov 2009 (HHS Reference No. E–047–
2009/0–US–01).
Licensing Status: Available for
licensing.
Licensing Contact: Fatima Sayyid.
M.H.P.M.; 301–435–4521;
Fatima.Sayyid@nih.hhs.gov.
Use of Immunosuppressive Agents for
Treatment of Age-related Macular
Degeneration (AMD) and Diabetic
Retinopathy
Description of Invention: AMD
belongs to a group of disorders in which
the immune system may play an
important role. This invention discloses
that patients with AMD gain additional
therapeutic benefit from combination
treatment of immunosuppressive agents
and standard-of-care in comparison to
standard-of-care alone. This invention
slows the progression of choroidal
neovascularization (CNV) and may have
implications for related pathologies,
including diabetic retinopathy. Clinical
data from a small, randomized pilot
clinical trial are available.
Applications
• A method of treatment for AMD.
• A method of treatment for diabetic
retinopathy.
• A method of treatment for diseases
associated with CNV.
Advantages
• Likely to be synergistic with
existing therapeutics.
• May enable repurposing of some
exiting immunosuppressive agents.
E:\FR\FM\27JYN1.SGM
27JYN1
Agencies
[Federal Register Volume 75, Number 143 (Tuesday, July 27, 2010)]
[Notices]
[Pages 43990-43992]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18303]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010-N-0368]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Pet Event Tracking Network--State, Federal Cooperation
to Prevent Spread of Pet Food Related Diseases
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the paperwork requirements for the proposed
Pet Event Tracking Network (PETNet) cooperative Federal and State
initiative.
DATES: Submit either electronic or written comments on the collection
of information by September 27, 2010.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B,
Rockville, MD 20850, 301-796-3793, Denver.presley@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section
[[Page 43991]]
3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in the Federal Register concerning
each proposed collection of information before submitting the
collection to OMB for approval. To comply with this requirement, FDA is
publishing notice of the proposed collection of information set forth
in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Pet Event Tracking Network--State, Federal Cooperation to Prevent
Spread of Pet Food Related Diseases--21 U.S.C. 342 and 343, Section
1002(b) of the FDA Amendments Act of 2007. Stat. 823 (2007) (OMB
Control No. 0910-NEW)
In August, 2008, FDA sponsored the ``Gateway to Food Protection''
meeting, also known as the ``50-State'' meeting. The meeting included
representatives from other Federal agencies, the States, localities,
territories, and tribal partners, and was held to address the
challenges necessary to ensure the safety of the U.S. food supply. Work
groups were formed during the meeting which met and produced
recommendations in specific topic areas. One of the workgroups, the
Outbreaks/Food-Borne and Feed-Borne Investigations Workgroup, created a
subgroup consisting of veterinarians, animal feed regulators, and
others involved with animal health issues. This subgroup developed an
ambitious proposal for an early warning system to identify, track and
report disease outbreaks in companion animals or contamination
incidents concerning pet food or animals feed, which they named PETNet.
The PETNet proposal was developed in response to the 2007 outbreak that
occurred in companion animals that was associated with the deliberate
adulteration of pet food components, such as wheat gluten, with
melamine. As envisioned by the subgroup at that time, PETNet would
include a system for reporting outbreaks and would be supported by
adequate diagnostic laboratory facilities and an established mechanism
for conducting national epidemiological investigations.
The PETNet subgroup subsequently met twice in face-to-face
meetings, in May and November, 2009, during which time the proposed
scope of PETNet was streamlined to focus the program on information
sharing, rather than epidemiology or other aspects. One of the main
concerns of FDA's State regulatory partners regarding FDA's handling of
the melamine incident was that many States provided information to FDA,
but the information reported by the States to FDA and other information
in the possession of FDA was not shared by FDA with the States. States
believed that if they had received more information about what was
going on in a timely manner, they could perhaps have taken appropriate
action to safeguard animal and the public health by using their own
regulatory authorities and resources. The agency agreed with the
States, and thus decided to focus PETNet on being a system for sharing
information between FDA, other Federal agencies, and the States about
food-borne illness outbreaks in companion animals. By the end of the
November, 2009, meeting, this revised vision of PETNet was firmly
established with many of the details about the system in place.
FDA is planning to implement an initiative called ``The Pet Event
Tracking Network'' (PETNet) that will allow FDA and its State partners
to quickly and effectively exchange information about outbreaks of
illness in companion animals associated with pet food. FDA has worked
closely with its Federal and State partners to develop the PETNet, and
believes that it will serve an important function in protecting the
public and animal health.
PETNet will be a secure, internet-based network comprised of the
FDA, other Federal agencies, and State regulatory agencies/officials
that have authority over pet food. The Network will provide timely and
relevant information about pet food-related incidents to FDA, the
States, and other Federal Government agencies charged with protecting
animal and public health. FDA intends to identify and invite State
participants from all 50 States to participate in PETNet. Members of
the network will be able to both receive alerts about pet food
incidents, as well as create alerts when they are aware of a pet food
incident within their jurisdiction. The information will be used to
help State and Federal regulators determine how best to use
inspectional and other resources to either prevent or quickly limit the
adverse events caused by adulterated pet food. Many states have
regulatory authority beyond that of the FDA and often can be in a
position to act independently of FDA with the information they will
receive from the Pet Event Tracking Network.
Use of the system, including the reporting of incidents by States
to the FDA, will be entirely voluntary. The PETNet system will be
housed in Food Shield, a proprietary software system, and will be
accessible only to members via password. The system will make use of a
standardized electronic form housed on FoodShield to collect and
distribute basic information about pet food-related incidents. The form
contains the following data elements, almost all of which are drop down
menu choices: The species involved, clinical signs, number of animals
exposed, number of animals affected, animal ages, date of onset, name
and type of pet food involved, the manufacturer and distributor of the
pet food (if known), the State where the incident occurred, the origin
of the information, whether there are supporting laboratory results,
and contact information for the reporting PETNet member (i.e. name,
telephone number). The form would be filled out and submitted by a
PETNet member on FoodShield, at which time it will be available to
other PETNet members. Thus, the information will be entered and
received by PETNet members in as close to real time as possible. FDA
has designed the form itself to contain only the essential information
necessary to alert PETNet members about pet food-related incidents. For
further information, such as laboratory results, PETNet members can
contact the reporting PETNet member.
FDA estimates the burden of this collection of information as
follows:
[[Page 43992]]
Table 1.--Estimated Reporting Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
21 U.S.C. Section 342 & 343/Section 1002(b) 2007 No. of Annual Frequency Total Annual Hours per
Amendments / Form FDA Respondents per Response Responses Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Form FDA 3756 50 10 500 20/60 167
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA estimates that each State will report (i.e., fill out the
PETNet form to alert other PETNet members about a pet food-related
incident) approximately 10 times per year. This estimate represents the
maximum number of reports that FDA expects a State to submit in a year,
and in many cases the number of reports submitted by a State will
probably be far less. FDA believes that, given the form only has 11
items and most are drop down fields, 20 minutes is a sufficient amount
of time to complete the form. State regulatory officials responsible
for pet food already possess computer systems and have the internet
access necessary to participate in PETNet, and thus there are no
capital expenditures associated with the reporting.
Regarding recordkeeping, State regulatory officials who report on
PETNet receive the reportable information from consumers in their
States in the course of their customary and regular duties. Further,
these individuals already maintain records of such consumer complaints
in the course of their duties which are sufficient for the purposes of
reporting on PETNet. Therefore, FDA believes that the proposed
collection of information does not have additional recordkeeping
requirements.
Dated: July 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-18303 Filed 7-26-10; 8:45 am]
BILLING CODE 4160-01-S